$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 3, 2025)
$330.74M
Market Cap
-
P/E Ratio
-1.78
EPS
$5.12
52 Week High
$0.24
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Relmada Therapeutics, Inc. is a clinical-stage biotechnology firm headquartered in New York, dedicated to pioneering novel therapies for central nervous system (CNS) disorders and related conditions. The company is advancing a promising pipeline targeting unmet medical needs in pain management and psychiatric disorders, leveraging innovative research and technology. With a strong emphasis on improving patient outcomes, Relmada is well-positioned to play a pivotal role in the dynamic CNS therapeutics landscape, potentially delivering transformative solutions for both patients and healthcare providers.
LPTX
VRAX
VHAI
IPG
IRBT
NVDA
ADAP
MARA
DNN
PFE
NIO
ITUB
BYND
INTC
PLTD
VALE
TSLA
ASST
MTSR
RR
NFLX
CAPR
BITF
IREN
LUMN
AMCR
PMAX
MRVL
HTOO
SOFI
PLUG
KDLY
AAL
SAND
BMY
CDE
AUR
SHOT
ZAPP
NCLH
ASBP
ARTL
CIFR
AMD
ALIT
WULF
CPNG
AEO
GTLB
PLTR
PSTG
F
ASAN
GOOGL
HOOD
GM
TLRY
TEVA
APH
M
CLSK
IVP
QBTS
NWL
VGFC
LPTX
VRAX
VHAI
IPG
IRBT
NVDA
ADAP
MARA
DNN
PFE
NIO
ITUB
BYND
INTC
PLTD
VALE
TSLA
ASST
MTSR
RR
NFLX
CAPR
BITF
IREN
LUMN
AMCR
PMAX
MRVL
HTOO
SOFI
PLUG
KDLY
AAL
SAND
BMY
CDE
AUR
SHOT
ZAPP
NCLH
ASBP
ARTL
CIFR
AMD
ALIT
WULF
CPNG
AEO
GTLB
PLTR
PSTG
F
ASAN
GOOGL
HOOD
GM
TLRY
TEVA
APH
M
CLSK
IVP
QBTS
NWL
VGFC